Duvortuxizumab Uses, Dosage, Side Effects and more
Duvortuxizumab is under investigation in clinical trial NCT02743546 (Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma).
| Trade Name | Duvortuxizumab |
| Generic | Duvortuxizumab |
| Duvortuxizumab Other Names | Duvortuxizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
